FDA Inspection 1177839 — Actimus Biosciences Private Limited
The FDA completed an inspection of Actimus Biosciences Private Limited on Jul 21, 2022 in Visakhapatnam. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 21, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Visakhapatnam (India)
Additional Details
Clinical BA/BE